NASDAQ · Financial Statements
Niki BioSolutions, Inc. (NIKI) Financial Statements
$4.00
NASDAQ: NIKI
Market Cap $325748
Overview Financials Dividend Niki BioSolutions, Inc. most recently reported annual revenue of $0, net profit of $-1.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2021 2022 2023 2024 2025 Revenue $2.0M $1.0M $0 $0 $0 Operating Profit $-19.0M $-18.0M $-11.0M $-4.0M $-2.0M Net Profit $-25.0M $-10.0M $-3.0M $-4.0M $-1.0M EPS $-715.00 $-275.00 $-62.00 $-78.00 $-19.00 Op Margin -1245.6% -1351.0% -2457.5% — —
Balance Sheet (USD)
Metric 2021 2022 2023 2024 2025 Total Assets $22.0M $21.0M $21.0M $16.0M $19.0M Total Liabilities $4.0M $13.0M $5.0M $4.0M $5.0M Cash $8.0M $2.0M $2.0M $1.0M $3.0M Borrowings $0 $7.0M $3.0M $3.0M $3.0M
Cash Flow (USD)
Metric 2021 2022 2023 2024 2025 Operating Cash Flow $-15.0M $-12.0M $-8.0M $-1.0M $-2.0M Investing Cash Flow $16.0M $2.0M $1.0M $0 $0 Financing Cash Flow $1.0M $0 $0 $0 $-1.0M Net Cash Flow $5.0M $-3.0M $-3.0M $-1.0M $3.0M Free Cash Flow $-15.0M $-13.0M $-8.0M $-1.0M $-2.0M
Valuation & Return Ratios
Metric Value PEG Ratio 0.00 EV / EBITDA -0.21 FCF Yield -139.00% Quick Ratio 0.78 Interest Coverage -5.48 Return 1Y — Return 3Y — Return 5Y —
Screens featuring this stock